Market Size of North America Renal Denervation Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 3.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Renal Denervation Devices Market Analysis
North America Renal Denervation Devices Market is expected to register a CAGR of 3% during the forecast period. The major factors responsible for the growth of the renal denervation devices market include the rising prevalence of hypertension and the long-lasting effect of the procedure.
High blood pressure is called hypertension. The prevalence of hypertension has been observing a significant rise, over the past few years in North American Countries. Generally, blood pressure rises and falls throughout the day, but it can damage one's heart and result in health problems if hypertension stays high for a long time.
According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of them, with high blood pressure, have their condition under control. High blood pressure had been the primary contributing cause of death for more than 410,000 Americans, in 2014. CDC also stated that high blood pressure costs the country USD 48.6 billion, every year. The high prevalence is not just limited to the United State, owing to the fact that the Canada and Mexico also have a high rate of hypertension.
Thus, owing to all of the aforementioned factors, the market studied is expected to witness high growth, in the coming years.
North America Renal Denervation Devices Industry Segmentation
As per the scope of this report, renal denervation devices are one of several innovative device-based interventional therapies, which help to control blood pressure. It is safe, minimally invasive, and does not leave any implants behind. The market studied is segmented by technology and geography.
| By Technology | |
| Radiofrequency-based | |
| Ultrasound-based | |
| Micro-infusion-based |
| Geography | |||||
|
North America Renal Denervation Devices Market Size Summary
The North America Renal Denervation Devices Market is poised for growth, driven by the increasing prevalence of hypertension and the enduring effects of renal denervation procedures. Hypertension, a condition characterized by persistently high blood pressure, has been on the rise in North America, affecting a significant portion of the adult population. This condition poses serious health risks and has substantial economic implications, with high blood pressure being a leading cause of mortality and incurring significant healthcare costs. The market is expected to expand as ultrasound-based renal denervation devices, which offer a minimally invasive solution to disrupt nerve impulses and lower blood pressure, gain traction. Clinical trials, such as the RADIOSOUND-HTN trial, have shown promising results, indicating that this approach may be more effective than traditional methods, thereby enhancing market prospects.
However, the market has faced challenges due to the COVID-19 pandemic, which disrupted procedures and affected the production and supply chain of renal denervation devices in North America. The fear of virus transmission led to the cancellation of many procedures, and lockdowns hindered manufacturing and delayed trials and product approvals. Despite these setbacks, the market remains competitive, with several key players like Medtronic PLC, St. Jude Medical Inc., and ReCor Medical Inc. holding significant market shares. These companies continue to lead the market, navigating the challenges and capitalizing on the growing demand for effective hypertension management solutions.
North America Renal Denervation Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Hypertension
-
1.2.2 Long Lasting Effect of the Procedure
-
-
1.3 Market Restraints
-
1.3.1 Painful Procedure
-
1.3.2 Stringent Approval Process for Renal Denervation Devices and Reimbursement Systems
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Technology
-
2.1.1 Radiofrequency-based
-
2.1.2 Ultrasound-based
-
2.1.3 Micro-infusion-based
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
-
North America Renal Denervation Devices Market Size FAQs
What is the current North America Renal Denervation Devices Market size?
The North America Renal Denervation Devices Market is projected to register a CAGR of 3% during the forecast period (2024-2029)
Who are the key players in North America Renal Denervation Devices Market?
Medtronic PLC, St. Jude Medical Inc. , ReCor Medical Inc, Ablative Solutions Inc and Mercator MedSystems are the major companies operating in the North America Renal Denervation Devices Market.
